Pharmacology News

Methylnaltrexone can effectively treat opioid-induced constipation in patients, including those with cancer, according to research to be presented at the American Society of Regional Anesthesia and Pain Medicine’s annual meeting.

Glucocorticoids should no longer be the “default” option for many patients with rheumatoid arthritis, according to authors of a new recommendation document presented at ACR Convergence 2020.

Three studies recently published in JAMA Internal Medicine evaluated the effects of tocilizumab against COVID-19.

New findings from the phase 3 LIBERTY trials showed that relugolix combination therapy significantly improved pain associated with uterine fibroids compared with placebo.

Gabapentin may be more effective than standard therapy for hyperemesis gravidarum, according to results of a small trial presented at this year’s virtual American College of Obstetrics and Gynecology Annual Clinical and Scientific Meeting.

Three analyses of the phase 3 AMPOWER study evaluated the safety and efficacy of an investigational vaginal pH regulator gel in preventing pregnancy, as well as sexual satisfaction among women receiving the gel.

High school students with nonmedical opioid misuse may have an increased risk for heroin use later in life, according to research published in the Journal of Addiction Medicine.

Medication affordability is a major issue in the United States. CMS estimates U.S. prescription drug expenditure was $335 billion in 2018, and recent studies have shown that the cost of prescription drugs is surging faster than any other medical service or good.

The offspring of women who used modafinil or armodafinil during pregnancy had a higher risk of major congenital malformations than the general population, data show.

A new virtual reality training program could help educate the public on how to respond to an opioid overdose, including how to properly use naloxone, according to research published Drug and Alcohol Dependence.